About 250mg Abirapro Abiraterone Acetate Tablet
Experience the sterling quality of 250mg Abirapro Abiraterone Acetate Tablets, renowned for their effectiveness in advanced prostate cancer therapy. Manufactured by Glenmark Pharmaceuticals Ltd. in India, this prescription-only medication offers the best price for those seeking favorable reviews and praiseworthy outcomes in mCRPC treatment. Abirapro is formulated with Abiraterone Acetate 250mg, combining select efficacy with safety when administered as directed by a physician. Each white to off-white, oval tablet comes in a bottle containing 120, ensuring consistent supply and convenience for adult patients.
Applications and Usage Methodology of Abirapro 250mg
Beyond its primary indication for metastatic castration-resistant prostate cancer (mCRPC), Abirapro 250mg, taken in combination with prednisone or prednisolone, is selectively effective in adult male patients. Administered orally with water, tablets must not be crushed or chewed. Its application is exclusive to adults and should be supervised by a healthcare professional. This medication demonstrates successful outcomes primarily in oncology clinics, hospitals, and specialized cancer treatment centers.
Packaging Details, Charges, and Quick Dispatch Policy
Abirapro 250mg comes in robust bottles containing 120 tablets, ensuring optimal preservation against light and moisture. The packaging bears a 24-month shelf life from manufacturing. Payment terms are flexible, and samples can be provided upon request, possibly subject to an outlay or charge. We prioritize quick dispatch post-payment to expedite access, supporting healthcare providers and patients with timely delivery across India and beyond.
FAQ's of 250mg Abirapro Abiraterone Acetate Tablet:
Q: How should Abirapro 250mg tablets be administered for optimal results?
A: Abirapro 250mg tablets should be swallowed whole with water, never crushed or chewed, and taken according to the dosage prescribed by your physician, typically alongside prednisone or prednisolone.
Q: What is the main benefit of using Abirapro 250mg in cancer therapy?
A: The principal benefit of Abirapro 250mg is its proven efficacy in slowing the progression of metastatic castration-resistant prostate cancer (mCRPC) when used as part of a prescribed treatment regimen.
Q: When is Abirapro 250mg contraindicated and who should avoid it?
A: Abirapro 250mg is not suitable for women, children, or patients with severe liver impairment, as its safety and efficacy have not been established in these populations.
Q: Where can Abirapro 250mg tablets be obtained?
A: Abirapro 250mg is available through licensed pharmacies, hospitals, and authorized suppliers in India, strictly with a valid prescription from a registered healthcare provider.
Q: What is the process for storage and handling of Abirapro tablets?
A: Store Abirapro 250mg tablets in a cool, dry place below 25C, protected from light and moisture, to maintain their effectiveness throughout their shelf life.
Q: How quickly can orders for Abirapro 250mg be dispatched?
A: Orders for Abirapro 250mg are processed and dispatched promptly upon receipt of payment, ensuring swift availability to patients and healthcare professionals.